T

Tarsa Therapeutics, Inc

2 employees

Tarsa Therapeutics develops an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Medical Device
Medical

Date founded

2009

Funding rounds raised

Total raised

$28M

from 10 investors over 10 rounds

T

Tarsa Therapeutics, Inc raised $10M on August 13, 2014

Investors: Square 1 Bank and Oxford Finance LLC

T

Tarsa Therapeutics, Inc raised $7M on May 29, 2014

Investors: Foresite Capital, Novo Holdings and MVM Partners

T

Tarsa Therapeutics, Inc raised $28M on March 16, 2012

Investors: Novo Holdings, Marker LLC, Foresite Capital and MVM Partners

T

Tarsa Therapeutics, Inc raised $24M on January 17, 2010

Investors: MVM Partners

FAQ